7 studies found for:    19001265 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy
Condition: Rhinitis, Allergic
Interventions: Drug: ALK Alutard birch or 5-grasses;   Drug: ALK diluent
2 Not yet recruiting Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Biological: ILIT with extract of causal allergen;   Biological: ILIT with normal saline;   Drug: Rescue medication for allergic rhinitis
3 Active, not recruiting Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy
Condition: Allergic Rhinitis
Interventions: Drug: ALK Alutard Birch and/or 5-grasses;   Drug: ALK Diluent
4 Completed Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis
Condition: Allergic Rhinitis
Intervention: Biological: Allergen extract
5 Recruiting Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
Condition: Allergic Rhinitis
Interventions: Drug: HollisterStier;   Drug: Normal saline
6 Active, not recruiting Safety of Lymph Node Injection for Allergen Immunotherapy
Condition: Allergic Rhinitis
Interventions: Biological: Grass pollen extract;   Other: Placebo injection
7 Completed A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy
Condition: Rhinoconjunctivitis Due to Grass Pollen Allergy
Intervention: Biological: Allergen specific immunotherapy

Indicates status has not been verified in more than two years